Endothelin Receptor Antagonists and Cardiovascular Diseases of Aging

ISSN： 1170-229X

Source： Drugs & Aging, Vol.18, Iss.6, 2001-06, pp. : 425-439

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glycoprotein IIb/IIIa Receptor Antagonists: Clinical Pharmacology in Cardiovascular Diseases of Aging

By Sebastian M. Makkar R.

Drugs & Aging, Vol. 15, Iss. 3, 1999-09 ,pp. : 207-218

Adis International

Access to resources Recommend Favorite

Therapeutic Potential for Endothelin Receptor Antagonists in Cardiovascular Disorders

By Spieker L.E. Noll G. Lüscher T.F.

American Journal of Cardiovascular Drugs, Vol. 1, Iss. 4, 2001-04 ,pp. : 293-303

Adis International

Access to resources Recommend Favorite

The role of endothelin receptor antagonists in cardiovascular pharmacotherapy

By Münter K. Kirchengast M.

Expert Opinion on Emerging Drugs, Vol. 6, Iss. 1, 2001-04 ,pp. : 3-11

Informa Healthcare

Access to resources Recommend Favorite

Mixed results with endothelin receptor antagonists in cardiovascular disorders

Inpharma, Vol. 1, Iss. 1307, 2001-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

Endothelin Receptor Antagonists - An Overview

Current Medicinal Chemistry, Vol. 9, Iss. 5, 2002-03 ,pp. : 549-575

Bentham Science Publishers

Access to resources Recommend Favorite